Global Human Insulin Sales Market Report 2021

Publisher Name :
Date: 22-Apr-2021
No. of pages: 128
Inquire Before Buying

The global Human Insulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Insulin Analogs and Biosimilars

- Human Insulin Biologics

Segment by Application

- Short Acting

- Intermediate Acting

- Long Acting

- Pre-Mix Insulin

The Human Insulin market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Insulin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- B. Braun

- Becton, Dickinson

- Biocon

- Biodel

- ELI Lilly

- Julphar

- NOVO Nordisk

- Sanofi

- Wockhardt

- Ypsomed

Global Human Insulin Sales Market Report 2021

Table of Contents
1 Human Insulin Market Overview
1.1 Human Insulin Product Scope
1.2 Human Insulin Segment by Type
1.2.1 Global Human Insulin Sales by Type (2016 & 2021 & 2027)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Human Insulin Segment by Application
1.3.1 Global Human Insulin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Human Insulin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Insulin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Insulin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Insulin Price Trends (2016-2027)
2 Human Insulin Estimates and Forecasts by Region
2.1 Global Human Insulin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Insulin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Insulin Sales Market Share by Region (2016-2021)
2.2.2 Global Human Insulin Revenue Market Share by Region (2016-2021)
2.3 Global Human Insulin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Insulin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Insulin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Insulin Estimates and Projections (2016-2027)
2.4.2 Europe Human Insulin Estimates and Projections (2016-2027)
2.4.3 China Human Insulin Estimates and Projections (2016-2027)
2.4.4 Japan Human Insulin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Insulin Estimates and Projections (2016-2027)
2.4.6 India Human Insulin Estimates and Projections (2016-2027)
3 Global Human Insulin Competition Landscape by Players
3.1 Global Top Human Insulin Players by Sales (2016-2021)
3.2 Global Top Human Insulin Players by Revenue (2016-2021)
3.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2020)
3.4 Global Human Insulin Average Price by Company (2016-2021)
3.5 Manufacturers Human Insulin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Insulin Market Size by Type
4.1 Global Human Insulin Historic Market Review by Type (2016-2021)
4.1.1 Global Human Insulin Sales Market Share by Type (2016-2021)
4.1.2 Global Human Insulin Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Insulin Price by Type (2016-2021)
4.2 Global Human Insulin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Insulin Sales Forecast by Type (2022-2027)
4.2.2 Global Human Insulin Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Insulin Price Forecast by Type (2022-2027)
5 Global Human Insulin Market Size by Application
5.1 Global Human Insulin Historic Market Review by Application (2016-2021)
5.1.1 Global Human Insulin Sales Market Share by Application (2016-2021)
5.1.2 Global Human Insulin Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Insulin Price by Application (2016-2021)
5.2 Global Human Insulin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Insulin Sales Forecast by Application (2022-2027)
5.2.2 Global Human Insulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Insulin Price Forecast by Application (2022-2027)
6 North America Human Insulin Market Facts & Figures
6.1 North America Human Insulin Sales by Company
6.1.1 North America Human Insulin Sales by Company (2016-2021)
6.1.2 North America Human Insulin Revenue by Company (2016-2021)
6.2 North America Human Insulin Sales Breakdown by Type
6.2.1 North America Human Insulin Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Insulin Sales Breakdown by Type (2022-2027)
6.3 North America Human Insulin Sales Breakdown by Application
6.3.1 North America Human Insulin Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Insulin Sales Breakdown by Application (2022-2027)
7 Europe Human Insulin Market Facts & Figures
7.1 Europe Human Insulin Sales by Company
7.1.1 Europe Human Insulin Sales by Company (2016-2021)
7.1.2 Europe Human Insulin Revenue by Company (2016-2021)
7.2 Europe Human Insulin Sales Breakdown by Type
7.2.1 Europe Human Insulin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Insulin Sales Breakdown by Type (2022-2027)
7.3 Europe Human Insulin Sales Breakdown by Application
7.3.1 Europe 128 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 128 Sales Breakdown by Application (2022-2027)
8 China Human Insulin Market Facts & Figures
8.1 China Human Insulin Sales by Company
8.1.1 China Human Insulin Sales by Company (2016-2021)
8.1.2 China Human Insulin Revenue by Company (2016-2021)
8.2 China Human Insulin Sales Breakdown by Type
8.2.1 China Human Insulin Sales Breakdown by Type (2016-2021)
8.2.2 China Human Insulin Sales Breakdown by Type (2022-2027)
8.3 China Human Insulin Sales Breakdown by Application
8.3.1 China 152 Sales Breakdown by Application (2016-2021)
8.3.2 China 152 Sales Breakdown by Application (2022-2027)
9 Japan Human Insulin Market Facts & Figures
9.1 Japan Human Insulin Sales by Company
9.1.1 Japan Human Insulin Sales by Company (2016-2021)
9.1.2 Japan Human Insulin Revenue by Company (2016-2021)
9.2 Japan Human Insulin Sales Breakdown by Type
9.2.1 Japan Human Insulin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Insulin Sales Breakdown by Type (2022-2027)
9.3 Japan Human Insulin Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Insulin Market Facts & Figures
10.1 Southeast Asia Human Insulin Sales by Company
10.1.1 Southeast Asia Human Insulin Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Insulin Revenue by Company (2016-2021)
10.2 Southeast Asia Human Insulin Sales Breakdown by Type
10.2.1 Southeast Asia Human Insulin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Insulin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Insulin Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Human Insulin Market Facts & Figures
11.1 India Human Insulin Sales by Company
11.1.1 India Human Insulin Sales by Company (2016-2021)
11.1.2 India Human Insulin Revenue by Company (2016-2021)
11.2 India Human Insulin Sales Breakdown by Type
11.2.1 India Human Insulin Sales Breakdown by Type (2016-2021)
11.2.2 India Human Insulin Sales Breakdown by Type (2022-2027)
11.3 India Human Insulin Sales Breakdown by Application
11.3.1 India Human Insulin Sales Breakdown by Application (2016-2021)
11.3.2 India Human Insulin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Insulin Business
12.1 B. Braun
12.1.1 B. Braun Corporation Information
12.1.2 B. Braun Business Overview
12.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 B. Braun Human Insulin Products Offered
12.1.5 B. Braun Recent Development
12.2 Becton, Dickinson
12.2.1 Becton, Dickinson Corporation Information
12.2.2 Becton, Dickinson Business Overview
12.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Becton, Dickinson Human Insulin Products Offered
12.2.5 Becton, Dickinson Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Business Overview
12.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Human Insulin Products Offered
12.3.5 Biocon Recent Development
12.4 Biodel
12.4.1 Biodel Corporation Information
12.4.2 Biodel Business Overview
12.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biodel Human Insulin Products Offered
12.4.5 Biodel Recent Development
12.5 ELI Lilly
12.5.1 ELI Lilly Corporation Information
12.5.2 ELI Lilly Business Overview
12.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ELI Lilly Human Insulin Products Offered
12.5.5 ELI Lilly Recent Development
12.6 Julphar
12.6.1 Julphar Corporation Information
12.6.2 Julphar Business Overview
12.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Julphar Human Insulin Products Offered
12.6.5 Julphar Recent Development
12.7 NOVO Nordisk
12.7.1 NOVO Nordisk Corporation Information
12.7.2 NOVO Nordisk Business Overview
12.7.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 NOVO Nordisk Human Insulin Products Offered
12.7.5 NOVO Nordisk Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Human Insulin Products Offered
12.8.5 Sanofi Recent Development
12.9 Wockhardt
12.9.1 Wockhardt Corporation Information
12.9.2 Wockhardt Business Overview
12.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wockhardt Human Insulin Products Offered
12.9.5 Wockhardt Recent Development
12.10 Ypsomed
12.10.1 Ypsomed Corporation Information
12.10.2 Ypsomed Business Overview
12.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ypsomed Human Insulin Products Offered
12.10.5 Ypsomed Recent Development
13 Human Insulin Manufacturing Cost Analysis
13.1 Human Insulin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Insulin
13.4 Human Insulin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Insulin Distributors List
14.3 Human Insulin Customers
15 Market Dynamics
15.1 Human Insulin Market Trends
15.2 Human Insulin Drivers
15.3 Human Insulin Market Challenges
15.4 Human Insulin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Human Insulin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Insulin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Insulin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Insulin Sales (K Doses) by Region (2016-2021)
Table 5. Global Human Insulin Sales Market Share by Region (2016-2021)
Table 6. Global Human Insulin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Insulin Revenue Share by Region (2016-2021)
Table 8. Global Human Insulin Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Human Insulin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Insulin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Insulin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Insulin Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Human Insulin Sales Share by Company (2016-2021)
Table 14. Global Human Insulin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Insulin Revenue Share by Company (2016-2021)
Table 16. Global Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin as of 2020)
Table 17. Global Human Insulin Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Human Insulin Manufacturing Sites and Area Served
Table 19. Manufacturers Human Insulin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Insulin Sales (K Doses) by Type (2016-2021)
Table 22. Global Human Insulin Sales Share by Type (2016-2021)
Table 23. Global Human Insulin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Insulin Price (USD/Dose) by Type (2016-2021)
Table 25. Global Human Insulin Sales Share by Type (2022-2027)
Table 26. Global Human Insulin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Insulin Revenue Share by Type (2022-2027)
Table 28. Global Human Insulin Price (USD/Dose) by Type (2022-2027)
Table 29. Global Human Insulin Sales (K Doses) by Application (2016-2021)
Table 30. Global Human Insulin Sales Share by Application (2016-2021)
Table 31. Global Human Insulin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Insulin Price (USD/Dose) by Application (2016-2021)
Table 33. Global Human Insulin Sales (K Doses) by Application (2022-2027)
Table 34. Global Human Insulin Sales Share by Application (2022-2027)
Table 35. Global Human Insulin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Insulin Revenue Share by Application (2022-2027)
Table 37. Global Human Insulin Price (USD/Dose) by Application (2022-2027)
Table 38. North America Human Insulin Sales (K Doses) by Company (2016-2021)
Table 39. North America Human Insulin Sales Market Share by Company (2016-2021)
Table 40. North America Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Insulin Revenue Market Share by Company (2016-2021)
Table 42. North America Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 43. North America Human Insulin Sales Market Share by Type (2016-2021)
Table 44. North America Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 45. North America Human Insulin Sales Market Share by Type (2022-2027)
Table 46. North America Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 47. North America Human Insulin Sales Market Share by Application (2016-2021)
Table 48. North America Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 49. North America Human Insulin Sales Market Share by Application (2022-2027)
Table 50. Europe Human Insulin Sales (K Doses) by Company (2016-2021)
Table 51. Europe Human Insulin Sales Market Share by Company (2016-2021)
Table 52. Europe Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Insulin Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Human Insulin Sales Market Share by Type (2016-2021)
Table 56. Europe Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Human Insulin Sales Market Share by Type (2022-2027)
Table 58. Europe Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Human Insulin Sales Market Share by Application (2016-2021)
Table 60. Europe Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Human Insulin Sales Market Share by Application (2022-2027)
Table 62. China Human Insulin Sales (K Doses) by Company (2016-2021)
Table 63. China Human Insulin Sales Market Share by Company (2016-2021)
Table 64. China Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Insulin Revenue Market Share by Company (2016-2021)
Table 66. China Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 67. China Human Insulin Sales Market Share by Type (2016-2021)
Table 68. China Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 69. China Human Insulin Sales Market Share by Type (2022-2027)
Table 70. China Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 71. China Human Insulin Sales Market Share by Application (2016-2021)
Table 72. China Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 73. China Human Insulin Sales Market Share by Application (2022-2027)
Table 74. Japan Human Insulin Sales (K Doses) by Company (2016-2021)
Table 75. Japan Human Insulin Sales Market Share by Company (2016-2021)
Table 76. Japan Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Insulin Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Human Insulin Sales Market Share by Type (2016-2021)
Table 80. Japan Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Human Insulin Sales Market Share by Type (2022-2027)
Table 82. Japan Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Human Insulin Sales Market Share by Application (2016-2021)
Table 84. Japan Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Human Insulin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Insulin Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Human Insulin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Insulin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Human Insulin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Human Insulin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Human Insulin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Human Insulin Sales Market Share by Application (2022-2027)
Table 98. India Human Insulin Sales (K Doses) by Company (2016-2021)
Table 99. India Human Insulin Sales Market Share by Company (2016-2021)
Table 100. India Human Insulin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Insulin Revenue Market Share by Company (2016-2021)
Table 102. India Human Insulin Sales by Type (2016-2021) & (K Doses)
Table 103. India Human Insulin Sales Market Share by Type (2016-2021)
Table 104. India Human Insulin Sales by Type (2022-2027) & (K Doses)
Table 105. India Human Insulin Sales Market Share by Type (2022-2027)
Table 106. India Human Insulin Sales by Application (2016-2021) & (K Doses)
Table 107. India Human Insulin Sales Market Share by Application (2016-2021)
Table 108. India Human Insulin Sales by Application (2022-2027) & (K Doses)
Table 109. India Human Insulin Sales Market Share by Application (2022-2027)
Table 110. B. Braun Corporation Information
Table 111. B. Braun Description and Business Overview
Table 112. B. Braun Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. B. Braun Human Insulin Product
Table 114. B. Braun Recent Development
Table 115. Becton, Dickinson Corporation Information
Table 116. Becton, Dickinson Description and Business Overview
Table 117. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Becton, Dickinson Human Insulin Product
Table 119. Becton, Dickinson Recent Development
Table 120. Biocon Corporation Information
Table 121. Biocon Description and Business Overview
Table 122. Biocon Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Biocon Human Insulin Product
Table 124. Biocon Recent Development
Table 125. Biodel Corporation Information
Table 126. Biodel Description and Business Overview
Table 127. Biodel Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Biodel Human Insulin Product
Table 129. Biodel Recent Development
Table 130. ELI Lilly Corporation Information
Table 131. ELI Lilly Description and Business Overview
Table 132. ELI Lilly Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. ELI Lilly Human Insulin Product
Table 134. ELI Lilly Recent Development
Table 135. Julphar Corporation Information
Table 136. Julphar Description and Business Overview
Table 137. Julphar Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Julphar Human Insulin Product
Table 139. Julphar Recent Development
Table 140. NOVO Nordisk Corporation Information
Table 141. NOVO Nordisk Description and Business Overview
Table 142. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. NOVO Nordisk Human Insulin Product
Table 144. NOVO Nordisk Recent Development
Table 145. Sanofi Corporation Information
Table 146. Sanofi Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Sanofi Description and Business Overview
Table 148. Sanofi Human Insulin Product
Table 149. Sanofi Recent Development
Table 150. Wockhardt Corporation Information
Table 151. Wockhardt Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Wockhardt Description and Business Overview
Table 153. Wockhardt Human Insulin Product
Table 154. Wockhardt Recent Development
Table 155. Ypsomed Corporation Information
Table 156. Ypsomed Description and Business Overview
Table 157. Ypsomed Human Insulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Ypsomed Human Insulin Product
Table 159. Ypsomed Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Human Insulin Distributors List
Table 163. Human Insulin Customers List
Table 164. Human Insulin Market Trends
Table 165. Human Insulin Market Drivers
Table 166. Human Insulin Market Challenges
Table 167. Human Insulin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 2. Global Human Insulin Sales Market Share by Type in 2021 & 2027
Figure 3. Insulin Analogs and Biosimilars Product Picture
Figure 4. Human Insulin Biologics Product Picture
Figure 5. Global Human Insulin Sales Market Share by Application in 2021 & 2027
Figure 6. Short Acting Examples
Figure 7. Intermediate Acting Examples
Figure 8. Long Acting Examples
Figure 9. Pre-Mix Insulin Examples
Figure 10. Global Human Insulin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Insulin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Human Insulin Sales (K Doses) Growth Rate (2016-2027)
Figure 13. Global Human Insulin Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 14. Global Human Insulin Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Human Insulin Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Human Insulin Sales (K Doses) Growth Rate (2016-2027)
Figure 18. Europe Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Human Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Human Insulin Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Human Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Human Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Insulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Human Insulin Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Human Insulin Players Market Share by Revenue in Human Insulin: 2016 & 2020
Figure 29. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Human Insulin Revenue Share by Type (2016-2021)
Figure 31. Global Human Insulin Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Human Insulin Revenue Share by Application (2016-2021)
Figure 33. Global Human Insulin Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Human Insulin Sales Market Share by Type in 2020
Figure 35. North America Human Insulin Sales Market Share by Application in 2020
Figure 36. Europe Human Insulin Sales Market Share by Type in 2020
Figure 37. Europe Human Insulin Sales Market Share by Application in 2020
Figure 38. China Human Insulin Sales Market Share by Type in 2020
Figure 39. China Human Insulin Sales Market Share by Application in 2020
Figure 40. Japan Human Insulin Sales Market Share by Type in 2020
Figure 41. Japan Human Insulin Sales Market Share by Application in 2020
Figure 42. Southeast Asia Human Insulin Sales Market Share by Type in 2020
Figure 43. Southeast Asia Human Insulin Sales Market Share by Application in 2020
Figure 44. India Human Insulin Sales Market Share by Type in 2020
Figure 45. India Human Insulin Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Human Insulin
Figure 48. Manufacturing Process Analysis of Human Insulin
Figure 49. Human Insulin Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs